TNFSF10 and hepatocellular carcinoma: The same findings were also confirmed with crystal violet assay (Fig. 3d), whereby co-treatment with Ad-ΔB/TRAIL and Ad-ΔB/IL-12 elicited more cytopathic effect on HCC cells than Ad-ΔB.